TIA Management: Should TIA Patients be Admitted? Should TIA Patients Get Combination Antiplatelet Therapy?
Transient ischemic attack (TIA) has gained increasing attention over the last 2 decades with the realization that the condition is common, portends potentially serious consequences, and, when identified early, can be evaluated and treated to modify future risk. In this review, we examine the issues of whether all TIA patients need admission and whether such patients should receive short-term dual antiplatelet therapy. Not all patients require admission if evaluation and treatment are done promptly. There may be a role for dual antiplatelet therapy, but the results of further clinical trials will help provide better clarity on which patients are the best candidates for this treatment.
Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence, RI, USA.
Christina
C
Mijalski
Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence, RI, USA.
Brian
B
Silver
antiplatelet; hospitalization; transient ischemic attack